Compare CSTL & TNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSTL | TNC |
|---|---|---|
| Founded | 2007 | 1870 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2019 | N/A |
| Metric | CSTL | TNC |
|---|---|---|
| Price | $40.31 | $80.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $46.00 | ★ $102.00 |
| AVG Volume (30 Days) | ★ 331.6K | 138.1K |
| Earning Date | 02-26-2026 | 02-17-2026 |
| Dividend Yield | N/A | ★ 1.55% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.91 |
| Revenue | $343,530,000.00 | ★ $1,240,800,000.00 |
| Revenue This Year | $2.54 | N/A |
| Revenue Next Year | N/A | $5.63 |
| P/E Ratio | ★ N/A | $27.48 |
| Revenue Growth | ★ 10.15 | N/A |
| 52 Week Low | $14.59 | $67.32 |
| 52 Week High | $42.18 | $90.44 |
| Indicator | CSTL | TNC |
|---|---|---|
| Relative Strength Index (RSI) | 57.91 | 65.69 |
| Support Level | $38.73 | $77.46 |
| Resistance Level | $41.60 | $79.44 |
| Average True Range (ATR) | 1.58 | 1.73 |
| MACD | -0.12 | 0.47 |
| Stochastic Oscillator | 62.75 | 94.35 |
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
Tennant Co is a manufacturer of floor cleaning equipment, wood flooring, and wood products. It operates in four geographic business units including North America; Latin America; Europe, Middle East, Africa; and Asia Pacific. The company offers products and solutions consisting of mechanized cleaning equipment, detergent-free, and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, specialty surface coatings, and business solutions such as financing, rental and leasing programs, and machine-to-machine asset management solutions.